Joint mimicking mechanical load activates TGFβ1 in fibrin-poly(ester-urethane) scaffolds seeded with mesenchymal stem cells by Gardner, OFW et al.
Joint mimicking mechanical load activates TGFβ1 in
fibrin-poly(ester-urethane) scaffolds seeded with
mesenchymal stem cells
Oliver F. W. Gardner1,2, Niamh Fahy1, Mauro Alini1 and Martin J. Stoddart1*
1AO Research Institute Davos, Davos Platz, Switzerland
2School of Biosciences, Cardiff University, UK
Abstract
Transforming growth factor-β1 (TGF-β1) is widely used in an active recombinant form to stimulate the chondrogenic
differentiation of mesenchymal stem cells (MSCs). Recently, it has been shown that the application of multiaxial load, that
mimics the loading within diarthrodial joints, to MSCs seeded in to ﬁbrin-poly(ester-urethane) scaffolds leads to the endogenous
production and secretion of TGF-β1 by the mechanically stimulated cells, which in turn drives the chondrogenic differentiation
of the cells within the scaffold. The work presented in this short communication provides further evidence that the application of
joint mimicking multiaxial load induces the secretion of TGF-β1 by mechanically stimulated MSCs. The results of this work also
show that joint-like multiaxial mechanical load activates latent TGF-β1 in response to loading in the presence or absence of cells;
this activation was not seen in non-loaded control scaffolds. Despite the application of mechanical load to scaffolds with
different distributions/numbers of cells no signiﬁcant differences were seen in the percentage of active TGF-β1 quantiﬁed in
the culture medium of scaffolds from different groups. The similar level of activation in scaffolds containing different numbers
of cells, cells at different stages of differentiation or with different distributions of cells suggests that this activation results from
the mechanical forces applied to the culture system rather than differences in cellular behaviour. These results are relevant when
considering rehabilitation protocols after cell therapy or microfracture, for articular cartilage repair, where increased TGF-β1
activation in response to joint mobilization may improve the quality of developing cartilaginous repair material. © 2016 The
Authors Journal of Tissue Engineering and Regenerative Medicine Published by John Wiley & Sons Ltd
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1. Introduction
Transforming growth factor β (TGF-β) is considered to be
one of the key factors involved in the chondrogenic differen-
tiation of mesenchymal stem cells (MSCs) and is required for
the classical chondrogenic differentiation of MSCs in vitro
(Johnstone et al., 1998). Transforming growth factor β is se-
creted by cells in an inactive, latent form in which the active
TGF-β peptide is bound to the latency associated peptide
(LAP). For TGF-β to bind to, and activate, a target receptor
the mature TGF-β peptide must ﬁrst be released from the
LAP (Robertson and Rifkin, 2013). This TGF-β activation
can occur in a variety of ways, including protease degrada-
tion (e.g. the serine protease plasmin), mechanical stimula-
tion, deglycosylation or the application of a number of
physiochemical stimuli such as heat, extremes of pH and ul-
traviolet (UV) light (Lyons et al., 1990; Robertson and Rifkin,
2013). Mechanical forces, in a number of different forms,
have been shown to activate TGF-β. Work by Annes et al.
(2004) andWipff et al. (2007) has shown that integrin bind-
ing and subsequent cell generated traction forces are
involved in the activation of TGF-β that is bound to extracel-
lular matrix via Latent tgfb binding protein (LTBP), while the
mechanical activation of TGF-β has also been demonstrated
in ﬂuid environments in response to the application of ﬂuid
shear stress or stirring forces (Annes et al., 2004; Wipff
et al., 2007; Ahamed et al., 2008; Albro et al., 2012). Work
by this group, using a custom built bioreactor, has shown that
the application of a combination of shear and compression
load, which mimics the load of a diarthrodial joint, induces
the chondrogenesis of human MSCs via the induction of
TGF-β1 secretion in stimulated cells (Li et al., 2010). This
work aimed to further investigate the effect of joint like load
on TGF-β1 by quantifying not only the effect of multiaxial
load on the overall production of TGF-β1 but also its activa-
tion. Cell seeding distribution was either uniform, as is com-
monly performed during tissue engineering studies, or
scaffolds contained the same number of cells but with a layer
seeded directly on top of the scaffold in order to mimic a su-
perﬁcial zone, as seen in cartilage. Cells seeded on top of the
scaffolds only was also included as a control.
2. Materials and methods
Human mesenchymal stem cells were isolated, with full
ethical approval, from bone marrow from four donors
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via density centrifugation separation and plastic adhe-
sion. The marrow aspirates used were either collected
from vertebral bodies (two females aged 18 years and
49 years, one male aged 22 years) or from the tibial
plateau (one male aged 48 years). Following isolation,
MSCs were expanded to passage four before being
seeded into ﬁbrin–poly(ester-urethane) scaffolds as de-
scribed previously (Li et al., 2009). The scaffolds were
Figure 1. Enzyme-linked immunosorbent assay (ELISA) data of endogenous transforming growth factor (TGF)-β1 generated in serum-free culture medium under static or mul-
tiaxial loading conditions. (a–d) Total endogenous TGF-β1 secreted into condition culture media from week 1 to week 4. (e–h) Activated TGF-β1 as a percentage of total TGF-β1
from week 1 to week 4. Statistical signiﬁcance was deﬁned as p ≤ 0.05 and determined using the Kruskal–Wallis and Dunn’s multiple comparison tests. *represents P ≤ 0.05,
**represents P ≤ 0.01, ***represents P ≤ 0.001 and ****represents P ≤ 0.0001 (n = 4 donors)
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seeded with cells in three different ways; group 1 scaf-
folds were evenly seeded with 4 million cells; group 2
scaffolds had 3.6 million cells seeded evenly within the
scaffold and 400 000 seeded on the loaded surface of
the scaffold; and group 3 scaffolds were seeded with just
400 000 cells on the loaded surface of the scaffold. Dif-
ferent seeding patterns were used to investigate the ef-
fect of different distributions and numbers of cells on
TGF-β1 activation. Following seeding, scaffolds were
cultured in media consisting of Dulbecco’s modiﬁed Ea-
gle’s medium 4.5 g/l glucose (Gibco, Carlsbad, CA,
USA), sodium pyruvate 0.11 g/l (Sigma-Aldrich, Buchs,
SG, Switzerland), L-ascorbic acid 2-phosphate
sesquimagnesium salt hydrate 50 μg/ml (Sigma-Al-
drich), dexamethasone 1 × 107 M (Sigma-Aldrich), in-
sulin transferrin and selenium 1% (Cyanogen,
Guangzhou, China), non-essential amino acids 1%
(Gibco), Primocin 0.1% (Invitrogen, San Diego, CA,
USA) and 6-aminocaproic acid 5 μM (Sigma-Aldrich).
Scaffolds were kept in free-swelling culture or were ex-
posed to 20 1-h cycles of 10% compression superimposed
on a 10% pre-strain and shear loading (± 25°) at 1 Hz for
1 h a day ﬁve times a week for 4 weeks. The culture media
was collected three times a week and pooled by week be-
fore being stored at 20°C for analysis.
To establish the direct effect of the mechanical environ-
ment, cell-free scaffolds were loaded with the same load-
ing protocol for 6 h in culture medium containing
20 ng/ml of latent TGF-β (R&D Systems, Minneapolis,
MN, USA).
The Human TGF-β 1 DuoSet ELISA (enzyme-linked im-
munosorbent assay) kit (R&D Systems) was used accord-
ing to the manufacturer’s instructions to quantify the
amount of TGF-β1 in the samples before and after activa-
tion in order to determine the percentage of active TGF-β1
in the samples.
Statistical analyses were performed using GraphPad
Prism 6 software (GraphPad Software Inc., La Jolla, CA,
USA). Cell free activation was assessed using the Stu-
dent’s t-test. The Shapiro–Wilk test was used to determine
normality and the Kruskal–Wallis and Dunn’s multiple
comparison tests used to determine signiﬁcance, which
was determined as p ≤ 0.05.
3. Results and discussion
The quantiﬁcation results for TGF-β1 show that mechani-
cal load leads to a signiﬁcant increase in the total amount
of TGF-β1 in culture media compared with control scaf-
folds in group 1 between weeks 2 and 4 of culture. In-
creased levels of total media TGF-β1 are also seen in
response to load group 2 loaded scaffolds compared with
controls; however, this was not signiﬁcant because of
raised levels of total media TGF-β1 in group 2 control scaf-
folds (Figure 1a–d). No change in media TGF-β1 content
was seen in group 3 in response to load over the 4-week
culture period.
Quantiﬁcation of the active TGF-β1 in each sample
show that in groups 1, 2 and 3 the percentage of active
TGF-β1 in each loaded group was signiﬁcantly increased
above the levels in all three control groups between weeks
2 and 4 of culture (Figure 1e–h). This clearly shows that
the application of joint mimicking load in this system
not only leads to an increase in the total production of
TGF-β1 but also induces the activation of the latent TGF-
β released by the MSCs.
Over the course of the 4 weeks in culture no signiﬁcant
differences were observed in the percentage of active
TGF-β1 between the three loaded groups, despite there
being different distributions of cells within the scaffolds
of different groups, the scaffolds of the three groups con-
taining different numbers of cells and the cells in the scaf-
folds of different groups being at different stages of
chondrogenic differentiation. This consistency in the de-
gree of TGF-β1 activation, regardless of the variation in
the cell populations within the scaffolds suggests that
the increase in the amount of active TGF-β1 in response
to load results from a physical activation similar to that
seen by others in response to mechanical load, particu-
larly shear, rather than a result of enzymatic activation
Figure 2. Latent transforming growth factor (TGF)-β was added to cell-free ﬁbrin polyurethane scaffolds and multiaxial load was applied for 6 h. (a) Activated TGF-β was only
detected in the loaded samples. (b) The active TGF-β as a percentage of total TGF-β detected in the medium reached similar levels to that found in cell containing scaffolds.
**p ≤ 0.001 N.D, not detected (n = 4 samples per group)
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owing to activity of the cells within the scaffold (Ahamed
et al., 2008, Albro et al., 2012). The inclusion in the media
of the protease inhibitor 6-aminocaproic acid in order to
prevent ﬁbrin degradation during culture also suggests
that this activation is unlikely to be caused by the activity
of plasmin as it is one of the enzymes inhibited by
6-aminocaproic acid (Kupcsik et al., 2009). To investigate
this further, latent TGF-β was added into a cell-free
system and the same loading protocol applied for 6 h.
No active TGF-β was measured in the unloaded control
(Figure 2). However, application of multiaxial load did
lead to activation of TGF-β, with the percentage of
activated TGF-β relative to total TGF-β detected in the
medium being comparable to that seen in the cell-
containing system (Figure 2b).
4. Conclusions
The present study shows that the application of jointmimick-
ing load to cartilage tissue engineering constructs leads not
only to the induction of latent TGF-β1 release into the culture
media, but also the activation of the secreted latent TGF-β1.
This activation appears to result from the physical forces
applied to the system rather than enzymatic activation, as
shown by activation in a cell-free system. These data are
particularly relevant when considering rehabilitation proto-
cols after cell therapy, or microfracture, for articular cartilage
repair as this work suggests that early mobilization of the
joint may increase TGF-β1 production and activation and
therefore promote chondrogenesis within repair tissue.
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